|
|
|
|
|
|
|
|
131st MAINE LEGISLATURE |
|
|
LD 1577 |
|
LR 655(02) |
|
|
|
An Act to Require
Health Insurance Coverage for Biomarker Testing |
|
Fiscal Note for
Bill as Amended by Committee Amendment " " |
|
Committee: Health Coverage, Insurance and
Financial Services |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fiscal Note |
|
|
|
|
|
|
|
|
|
|
FY 2023-24 |
FY 2024-25 |
Projections FY 2025-26 |
Projections FY 2026-27 |
| Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$0 |
$170,000 |
$359,565 |
$359,565 |
|
Highway Fund |
|
$0 |
$0 |
$7,221 |
$7,221 |
|
|
|
|
|
|
|
| Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$0 |
$170,000 |
$359,565 |
$359,565 |
|
Highway Fund |
|
$0 |
$0 |
$7,221 |
$7,221 |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
This bill
requires carriers offering health plans in this State to provide coverage,
including coverage in the MaineCare program, for biomarker testing. The
requirements of the bill apply to health plans issued or renewed on or after
January 1, 2025. The bill includes General Fund appropriations to the
Department of Administrative and Financial Services of $170,000 for the
estimated cost to reimburse insurance carriers for 6 months of the State's
defrayal cost of this new mandate. The mandate will go into effect on all
health insurance plans on the marketplace beginning January 1, 2025 and is
estimated to cost $340,000 annually thereafter. |
|
The State
Employee Health Plan's first impacted plan year will be SFY 2026 and is
estimated to cost $43,335 annually thereafter. The costs are split across the
General Fund ($19,565), Highway Funds ($7,221) and all other funds ($16,549). |
|
|
|
|
|
|
|